Vanda Pharmaceuticals Inc. (VNDA)

NASDAQ

$4.09

$--

(0.00%)

Pre-Market

Vanda Pharmaceuticals Inc. (VNDA) Live Price Chart

Last updated: ⁦2026-10-22 09:33:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Vanda Pharmaceuticals Inc. (VNDA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4.09, with a market capitalization of $252.13M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.97 to $9.94. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$252.13M
Open	$4.09
Day's High	$33.44
Day's Low	$0.45
Previous Close	$4.01
Volume	218.00
Average Volume	970.58K
P/E Ratio	--
52-Week High	$9.94
52-Week Low	$3.97
Dividend Yield	--
Earnings Date	--

Vanda Pharmaceuticals Inc. (VNDA) Pre-Market Stock Price

Vanda Pharmaceuticals Inc. (VNDA) is trading at $4.09 in pre-market trading as of 2026-10-22 09:08:00, up 1.87% ($0.08) from the previous close of $4.01

Pre-market trading shows how investors are pricing VNDA before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Vanda Pharmaceuticals Inc. (VNDA) 7-Day Stock Price Change

Over the past seven days, Vanda Pharmaceuticals Inc. (VNDA) moved from $4.30 to $4.09, representing a decline of 5.00% ($0.21).

The stock traded between $3.97 and $4.54 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 933.85 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

VNDA 52-Week Price Position

Position in Range: 2.0%

52W Low$3.97

52W High$9.94

VNDA is currently trading at $4.09, placing it 2.0% of the way from its 52-week low of $3.97 to its 52-week high of $9.94. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Vanda Pharmaceuticals Inc. (VNDA)?

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Vanda Pharmaceuticals Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	533
Exchange	NASDAQ
Company Website	https://www.vandapharma.com

How to Buy Vanda Pharmaceuticals Inc. (VNDA) Stock on MEXC

Eligible investors can buy real shares of Vanda Pharmaceuticals Inc. (VNDA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for VNDA and Place Your Order

Open the RealStocks trading page and search for VNDA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Vanda Pharmaceuticals Inc. (VNDA) stock price today?

Vanda Pharmaceuticals Inc. (VNDA) is currently trading at $ 4.09, up 1.87% ($0.08) from the previous close of $ 4.01. Intraday prices update in real time during regular trading hours.

2.Is VNDA stock going up or down today?

As of 2026-10-22 09:08:00, VNDA is trading at $ 4.09, up 1.87% ($0.08) from its previous close of $ 4.01. The stock has traded between $ 0.45 and $ 33.44 during today’s regular session. Past price movements do not guarantee future results.

3.What is VNDA pre-market price?

As of 2026-10-22 09:08:00, VNDA is trading at $ 4.09 in pre-market trading, up 1.87% ($0.08) from the previous close of $ 4.01. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is VNDA after-hours price?

As of 2026-10-22 09:08:00, VNDA is trading at $ 4.08 in after-hours trading, up 1.85% ($0.07) from the regular-session close of $ 4.01. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is VNDA stock trading now?

VNDA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does VNDA sit relative to its 52-week high and low?

Over the past 52 weeks, VNDA has traded between a low of $ 3.97 and a high of $ 9.94. At $ 4.09, the stock is positioned 2.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Vanda Pharmaceuticals Inc. in?

Vanda Pharmaceuticals Inc. (VNDA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Vanda Pharmaceuticals Inc.'s market capitalization and where is it listed?

Vanda Pharmaceuticals Inc. is listed on the NASDAQ exchange with a market capitalization of $ 252.13M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is VNDA valued in terms of P/E ratio and EPS?

VNDA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -4.55. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Vanda Pharmaceuticals Inc. pay a dividend?

Vanda Pharmaceuticals Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.